Catalog No.: PC-49117Not For Human Use, Lab Use Only.
Ansornitinib (ANG-3070, ANG3070) is an oral fibrokinase inhibitor inhibitor of PDGFR and VEGFR/KDR with high binding affinity, also targets Discoidin Domain Receptors 1 and 2 (DDR1 and DDR2), tyrosine kinase receptors linked to the development of fibrosis in the kidneys and lungs.
Ansornitinib (ANG-3070, ANG3070) is an oral fibrokinase inhibitor inhibitor of PDGFR and VEGFR/KDR with high binding affinity, also targets Discoidin Domain Receptors 1 and 2 (DDR1 and DDR2), tyrosine kinase receptors linked to the development of fibrosis in the kidneys and lungs.
Ansornitinib (ANG-3070, ANG3070) exhibits limited interaction with other receptor tyrosine kinases
Ansornitinib (ANG-3070, ANG3070) has demonstrated beneficial effects in chronic kidney disease animal models.
